Real-time PCR targeting
lytA
(the major autolysin gene) and
piaB
(permease gene of the
pia
ABC transporter) are currently used as the gold-standard culture-independent assays for
Streptococcus pneumoniae
identification. We evaluated the performance of a new real-time PCR assay – targeting SP2020 (putative transcriptional regulator gene) – and compared its performance with the assays previously described. A collection of 150 pneumococci, 433 non-pneumococci and 240 polymicrobial samples (obtained from nasopharynx, oropharynx, and saliva; 80 from each site) was tested. SP2020 and
lytA
-CDC assays had the best performance (sensitivity of 100% for each compared to 95.3% for
piaB
). The specificity for
lytA
and
piaB
was 99.5% and for SP2020 was 99.8%. Misidentifications occurred for the three genes:
lytA
,
piaB
and SP2020 were found in non-pneumococcal strains;
piaB
was absent in some pneumococci including a serotype 6B strain. Combining
lytA
and SP2020 assays resulted in no misidentifications. Most polymicrobial samples (88.8%) yielded concordant results for the three molecular targets. The remaining samples seemed to contain non-typeable pneumococci (0.8%), and non-pneumococci positive for
lytA
(1.7%) or SP2020 (8.7%). We propose that combined detection of both
lytA
-CDC and SP2020 is a powerful strategy for the identification of pneumococcus either in pure cultures or in polymicrobial samples.
Streptococcus pneumoniae
(pneumococcus) is a major human respiratory pathogen linked with high morbidity, mortality, and health care-associated costs worldwide. This bacterium often colonizes asymptomatically healthy children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.